Financials data is unavailable for this security.
View more
Year on year Dr. Lal PathLabs Ltd grew revenues 10.40% from 20.17bn to 22.27bn while net income improved 49.78% from 2.39bn to 3.58bn.
Gross margin | 80.28% |
---|---|
Net profit margin | 17.33% |
Operating margin | 21.95% |
Return on assets | 16.13% |
---|---|
Return on equity | 21.27% |
Return on investment | 20.12% |
More ▼
Cash flow in INRView more
In 2024, Dr. Lal PathLabs Ltd increased its cash reserves by 36.86%, or 972.02m. The company earned 5.35bn from its operations for a Cash Flow Margin of 24.04%. In addition the company used 242.69m on investing activities and also paid 4.14bn in financing cash flows.
Cash flow per share | 65.91 |
---|---|
Price/Cash flow per share | 44.85 |
Book value per share | 240.30 |
---|---|
Tangible book value per share | 140.97 |
More ▼
Balance sheet in INRView more
Current ratio | 2.87 |
---|---|
Quick ratio | 2.77 |
Total debt/total equity | 0.0992 |
---|---|
Total debt/total capital | 0.0889 |
More ▼
Growth rates in INR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 100.00% and 49.56%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg) | 0.74% |
---|---|
Div growth rate (5 year) | 31.95% |
Payout ratio (TTM) | 24.89% |
EPS growth(5 years) | 12.22 |
---|---|
EPS (TTM) vs TTM 1 year ago | 33.00 |
More ▼